Fundz

CytoSorbents Receives $1.1 Million in Non-Dilutive Funding from the New Jersey Business Tax Certificate Transfer Program

PUBLIC · CTSOApr 29, 2020

Amount Raised

$1 Million

Round Type

Seed

Monmouth JunctionManufacturingBiotechnologyHealth Care

Description

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, today announced that it has received $1,092,698, net of transaction costs, in non-dilutive funding as an approved participant of the Technology Business Tax Certificate Transfer Program sponsored by the New Jersey Economic Development Authority (NJEDA).

Quick answer

CytoSorbents Corporation raised $1 Million in a Seed round, dated April 29, 2020. CytoSorbents Corporation is based in Monmouth Junction, New Jersey, United States.

How much did CytoSorbents Corporation raise?
CytoSorbents Corporation raised $1 Million in a Seed round on April 29, 2020.
What does CytoSorbents Corporation do?
CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology.
Where is CytoSorbents Corporation based and how big is it?
CytoSorbents Corporation is based in Monmouth Junction, New Jersey, United States. Fundz records about 201 employees.
Who are the decision-makers at CytoSorbents Corporation?
Fundz holds 1 contact at CytoSorbents Corporation, including the CEO . Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as CytoSorbents Corporation that raised within 45 days of this round, from Fundz verified event records.

  • Cerenome, Inc. raised $300K (Seed) on May 22, 2020.
  • Novabay raised $1K on May 22, 2020.
  • AseptiScope, Inc. raised $4.2M (Seed) on May 20, 2020.
  • Shape Memory Medical raised $5.8M on May 18, 2020.
  • Helus Pharma raised $477K on May 5, 2020.
  • Novabay raised an undisclosed amount on May 1, 2020.

Who to call at CytoSorbents Corporation, and when

A new round usually means CytoSorbents Corporation is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CytoSorbents Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CytoSorbents Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CytoSorbents Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CytoSorbents Corporation

Location

Monmouth Junction, New Jersey, United States

About

CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology. CytoSorbents is a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is distributed in more than 70 countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CytoSorbents Corporation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPhillip C., CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CytoSorbents Corporation's next move

See what Strategic adds

CytoSorbents Corporation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.